Bioresorbable Bone Fixation Devices

New devices for fixating bone fractures are designed to provide greater compressive strength through the incorporation of new technology and specially formulated resorbable materials. The devices have been cleared by the US Food and Drug Administration (FDA).

The new technology, called BIO-CLASP (compression locking anchor with secondary purchase), was developed by Triage Medical, Inc. (Irvine, CA, USA). The company says no other fixation device can provide the strength of the CLASP technology even in the presence of osteoporotic bone. In a number of tests, the Traige devices have shown greater compression strength than competitive metal and bioresorbable product designs. The bioresorbable material eliminates the need for a secondary surgery to remove metallic hardware at the site of a bone fracture.

Triage is developing similar devices for additional clinical indications, including the hip, craniomaxillofacial regions, and the hand. The company has also begun a development program to utilize the CLASP technology for a less-invasive procedure, percutaneous bilateral fusion (PBF) for the treatment of selected spinal conditions.



Related Links:
Triage Medical